In addition, immunohistochemical (IHC) staining and Western blot analyses of clinical glioma tissue samples revealed a strong positive correlation between SP1 and TRIM56 expression (Fig. 2M and Supplementary Fig. 4U, W). This evidence concerns the gene SP1 and central nervous system cancer.